Rajiv Khosla
Vorstandsvorsitzender bei Enteris BioPharma, Inc.
Profil
Rajiv Khosla currently works at Enteris BioPharma, Inc., as Chief Executive Officer.
Dr. Khosla also formerly worked at IntelGenx Technologies Corp., as President, Chief Executive Officer & Director from 2013 to 2014, Orasi Medical, Inc., as President, Chief Executive Officer & Director from 2011 to 2012, Sensient Technologies Corp., as Vice President & General Manager-Pharmaceutical in 2005, and Intelgenx Corp., as Chief Operating & Scientific Officer from 2013 to 2014.
Dr. Khosla received his Masters Business Admin degree from Henley Business School Ltd.
and undergraduate degree from The University of Nottingham.
Aktive Positionen von Rajiv Khosla
Unternehmen | Position | Beginn |
---|---|---|
Enteris BioPharma, Inc.
Enteris BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Enteris BioPharma, Inc. operates as a clinical stage biopharmaceutical company. It offers formulation solutions built around its proprietary oral drug delivery technologies. The company was founded in 2013 and is headquartered in Boonton, NJ. | Vorstandsvorsitzender | - |
Ehemalige bekannte Positionen von Rajiv Khosla
Unternehmen | Position | Ende |
---|---|---|
INTELGENX TECHNOLOGIES CORP. | Vorstandsvorsitzender | 15.07.2014 |
Orasi Medical, Inc.
Orasi Medical, Inc. Medical/Nursing ServicesHealth Services Orasi Medical, Inc. is a privately held, early stage medical device company engaged in the development and commercialization of technology to diagnose and monitor neurological diseases. They have developed a painless, non-invasive test that takes less than ten (10) minutes to administer and, based on the results of its current research, is more accurate than current clinical practice. Initially, its aim is to develop the first FDA cleared test for the diagnosis of Alzheimer's disease. In addition, they are developing products for pharmaceutical companies to measure treatment effect and reduce the cost of clinical drug trials for neurological diseases. Ultimately, its long-term goal is to set the standard of care for diagnosis and monitoring of major neurological diseases such as Alzheimer's disease, multiple sclerosis, Parkinson's, autism, depression and attention deficit hyperactivity disorder (ADHD). | Präsident | 18.08.2012 |
SENSIENT TECHNOLOGIES CORPORATION | Corporate Officer/Principal | 01.01.2005 |
Intelgenx Corp.
Intelgenx Corp. Pharmaceuticals: MajorHealth Technology Intelgenx Corp. develops oral-controlled release pharmaceutical products. The firm offers pharmaceuticals services to pharmaceutical partners, including R&D, analytical method development, clinical monitoring, IP and regulatory services. The company was founded in 2003 and is headquartered in Saint-Laurent, Canada. | Vorstandsvorsitzender | - |
Ausbildung von Rajiv Khosla
The University of Nottingham | Undergraduate Degree |
Henley Business School Ltd. | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
SENSIENT TECHNOLOGIES CORPORATION | Consumer Non-Durables |
INTELGENX TECHNOLOGIES CORP. | Health Technology |
Private Unternehmen | 3 |
---|---|
Orasi Medical, Inc.
Orasi Medical, Inc. Medical/Nursing ServicesHealth Services Orasi Medical, Inc. is a privately held, early stage medical device company engaged in the development and commercialization of technology to diagnose and monitor neurological diseases. They have developed a painless, non-invasive test that takes less than ten (10) minutes to administer and, based on the results of its current research, is more accurate than current clinical practice. Initially, its aim is to develop the first FDA cleared test for the diagnosis of Alzheimer's disease. In addition, they are developing products for pharmaceutical companies to measure treatment effect and reduce the cost of clinical drug trials for neurological diseases. Ultimately, its long-term goal is to set the standard of care for diagnosis and monitoring of major neurological diseases such as Alzheimer's disease, multiple sclerosis, Parkinson's, autism, depression and attention deficit hyperactivity disorder (ADHD). | Health Services |
Intelgenx Corp.
Intelgenx Corp. Pharmaceuticals: MajorHealth Technology Intelgenx Corp. develops oral-controlled release pharmaceutical products. The firm offers pharmaceuticals services to pharmaceutical partners, including R&D, analytical method development, clinical monitoring, IP and regulatory services. The company was founded in 2003 and is headquartered in Saint-Laurent, Canada. | Health Technology |
Enteris BioPharma, Inc.
Enteris BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Enteris BioPharma, Inc. operates as a clinical stage biopharmaceutical company. It offers formulation solutions built around its proprietary oral drug delivery technologies. The company was founded in 2013 and is headquartered in Boonton, NJ. | Health Technology |